Navigation Links
Congenital rubella syndrome nearly eradicated in the US

Congenital rubella syndrome, a birth defect caused by the rubella virus (also known as German measles), has practically been eliminated in the U.S., according to a statement published in the April 2006 issue of Birth Defects Research Part A, the official journal of The Teratology Society. The journal is available online via Wiley InterScience at http://www3.interscience.wiley.com/cgi-bin/jhome/102526943.

Endorsed by the Teratology Society, the Organization of Teratology Information Specialists (OTIS), the Neurobehavioral Teratology Society, and the Behavioral Toxicology Society, the statement notes that rubella is no longer an endemic disease in this country and congenital rubella syndrome "is almost a thing of the past in the United States." Birth defects resulting from rubella may include blindness, deafness, and congenital heart disease. A rubella epidemic in the early 1960s caused more than 11,000 fetal deaths and 20,000 infants to be born with congenital rubella syndrome, but a more effective vaccine introduced in the 1970s has helped in eliminating transmission of rubella from expectant mothers to their unborn babies.

"Effectively, congenital rubella syndrome has been nearly eradicated from the United States," according to the statement. There were fewer than 10 cases or rubella reported in the U.S. last year and in the past 5 years there have only been 4 cases of congenital rubella syndrome reported, only one of which was in a child whose mother had been born in the U.S.

The remarkable success of the immunization program to eliminate rubella is due to joint efforts by the Centers for Disease Control and Prevention, various state and local health departments, the American Academy of Pediatrics, the American College of Obstetrics and Gynecology, and the March of Dimes, according to the statement. Maintaining high rubella immunization rates is crucial to the continue d success of these efforts. The statement concludes: "Effective strategies, such as continued universal childhood and adolescent immunization, must be secured to extend this success worldwide."


'"/>

Source:John Wiley & Sons, Inc.


Related biology news :

1. 15-year hunt finds cause of pseudothalidomide syndrome
2. Gene for immune deficiency syndromes found
3. Removing DNA repair gene causes metabolic syndrome
4. Researchers link two more genes to sudden infant death syndrome
5. Down syndrome: Its not just the age factor
6. A potential biological cause for sudden infant death syndrome
7. Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows
8. Angelman syndrome deficits rescued in mice
9. Chronic fatigue syndrome impairs a persons slow wave activity during sleep
10. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
11. Breast tumors in mice eradicated using cancer vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
Breaking Biology Technology: